Cargando…

Saying No to Cameras in the Emergency Department

Detalles Bibliográficos
Autor principal:	Geiderman, Joel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	California Chapter of the American Academy of Emergency Medicine 2003
Materias:	CaJEM Pro/Con
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390510/ https://www.ncbi.nlm.nih.gov/pubmed/28512532

Ejemplares similares

Rebuttal to “Saying No...”
por: Clements, R. Carter
Publicado: (2003)

Rebuttal to “Pro Filming in the ED”
por: Geidesman, Joel
Publicado: (2003)

Pro Position for Filming in The ED
por: Clements, R. Carter
Publicado: (2003)

Why the US Should Adopt a Universal Health Care Coverage Program
por: Brown, Lance
Publicado: (2004)

Combining the Modified Allen’s Test and Pulse Oximetry for Evaluating Ulnar Collateral Circulation to the Hand for Radial Artery Catheterization of the ED Patient
por: Paul, Benjamin Z.S., et al.
Publicado: (2003)

When looking at a non-contrast head CT, what actually appears white in an acute hemorrhagic stroke?
por: Stein, John, et al.
Publicado: (2002)

From the Cal/AAEM representative on the CAL/ACEP Governmental Affairs Committee
por: Lotfipour, Shahram
Publicado: (2002)

Should Academic Emergency Departments Collaborate in Pharmaceutical Industry-Sponsored Research?: The Dangers of Industry-Funded Research in Emergency Medicine
por: Stone, Susan, et al.
Publicado: (2003)

Interacting with the Pharmaceutical Industry
por: Hayden, Stephen R.
Publicado: (2003)

Advantages of a Three-year Residency
por: Langdorf, Mark, et al.
Publicado: (2004)

Why the US Government Should Not Adopt a Universal Health Coverage Program
por: Montauk, Lance
Publicado: (2004)

Con: Should Evidence-Based Medicine Be Used More in Clinical Practice?
por: Maxim, Preston
Publicado: (2006)

Rebuttal of Con
por: Fee, Chris
Publicado: (2006)

Rebuttal of Pro
por: Maxim, Preston
Publicado: (2006)

Pro: Should Evidence-Based Medicine Be Used More in Clinical Practice?
por: Fee, Chris
Publicado: (2006)

Pro: Venoarterial ECMO Should Be Considered in Patients With COVID-19
por: Bhatia, Meena, et al.
Publicado: (2021)

Con: Venoarterial ECMO Should Not Be Considered in Patients With COVID-19
por: McLean, Duncan J., et al.
Publicado: (2021)

Con: Integrated 5-Year Anesthesiology Residency Should Be Implemented Widely
por: Phillips, Thomas
Publicado: (2023)

Pro: Integrated Five-Year Anesthesiology Residency Should Be Implemented Widely
por: Kovar, Alan J., et al.
Publicado: (2023)

Ultrasound-Guided Deep Brachial and Basilic Vein Cannulation in the Emergency Department
por: Wang, Ralph, et al.
Publicado: (2005)

Should we offer preventive treatment to all carriers of PLN p.(Arg14del) variant?: Pro: Provide pre-emptive treatment to asymptomatic carriers
por: de Boer, Rudolf A.
Publicado: (2023)

Should we offer preventive treatment to all carriers of PLN p.(Arg14del) variant?: Con: Do no harm to asymptomatic carriers
por: Doevendans, Pieter A.
Publicado: (2023)

Dietary sodium and cardiovascular and renal disease risk factors: dark horse or phantom entry?
por: McCarron, David A.
Publicado: (2008)

Is too much salt harmful? Yes
por: Agócs, Róbert, et al.
Publicado: (2019)

Pro con debates in clinical medicine infection prevention and control in cystic fibrosis: One size fits all? The argument in favour
por: Haggie, S., et al.
Publicado: (2020)

Congenital nephrotic syndrome: is early aggressive treatment needed? Yes
por: Hölttä, Tuula, et al.
Publicado: (2020)

Anthracyclines in the treatment of patients with early breast cancer
por: Guarneri, V., et al.
Publicado: (2022)

The term CAKUT has outlived its usefulness: the case for the prosecution
por: Woolf, Adrian S.
Publicado: (2022)

The term CAKUT has outlived its usefulness: the case for the defense
por: Knoers, Nine V. A. M.
Publicado: (2022)

FOLFOXIRI plus bevacizumab as standard of care for first-line treatment in patients with advanced colon cancer
por: Cervantes, A., et al.
Publicado: (2023)

Systemic treatment of metastatic hormone-sensitive prostate cancer—upfront triplet versus doublet combination therapy
por: Oing, C., et al.
Publicado: (2023)

Therapy of membranous nephropathy: quo vadis?
por: Glassock, Richard J
Publicado: (2023)

The place of cyclical therapy for the treatment of membranous nephropathy in the era of rituximab
por: Alberici, Federico, et al.
Publicado: (2023)

Anti-CD20 should be the first-line treatment in high-risk membranous nephropathy
por: Zand, Ladan, et al.
Publicado: (2023)

When comparing the safety of drugs, don't forget the exposure dimension
por: Zoccali, Carmine
Publicado: (2023)

Pharmacological strategies to manage hyperkalaemia: out with the old, in with the new? Not so fast…
por: Carrero, Juan Jesus, et al.
Publicado: (2023)

Sodium polystyrene is unsafe and should not be prescribed for the treatment of hyperkalaemia: primum non nocere!
por: Rossignol, Patrick, et al.
Publicado: (2023)

Validation of the Achalasia Patient‐Reported Outcomes Questionnaire
por: Pandolfino, John E., et al.
Publicado: (2022)

Is food addiction a valid and useful concept?
por: Ziauddeen, H, et al.
Publicado: (2013)

Infection prevention and control in cystic fibrosis: One size fits all?
por: Lands, Larry C.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ecm2ojehqk69qg2ni2bki7kt2g